33 related articles for article (PubMed ID: 8847567)
1. Targeting Cell Cycle Checkpoint Kinases to Overcome Intrinsic Radioresistance in Brain Tumor Cells.
Vlatkovic T; Veldwijk MR; Giordano FA; Herskind C
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158967
[TBL] [Abstract][Full Text] [Related]
2. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
[TBL] [Abstract][Full Text] [Related]
3. Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies.
Thaker NG; Pollack IF
Expert Rev Neurother; 2009 Dec; 9(12):1815-36. PubMed ID: 19951140
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy in conjunction with 7-hydroxystaurosporine: a multimodal approach with tumor pO2 as a potential marker of therapeutic response.
Khan N; Mupparaju SP; Hou H; Lariviere JP; Demidenko E; Swartz HM; Eastman A
Radiat Res; 2009 Nov; 172(5):592-7. PubMed ID: 19883227
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.
Pavlick AC; Wu J; Roberts J; Rosenthal MA; Hamilton A; Wadler S; Farrell K; Carr M; Fry D; Murgo AJ; Oratz R; Hochster H; Liebes L; Muggia F
Cancer Chemother Pharmacol; 2009 Sep; 64(4):803-10. PubMed ID: 19221754
[TBL] [Abstract][Full Text] [Related]
6. AG490 influences UCN-01-induced cytotoxicity in glioma cells in a p53-dependent fashion, correlating with effects on BAX cleavage and BAD phosphorylation.
Jane EP; Premkumar DR; Pollack IF
Cancer Lett; 2007 Nov; 257(1):36-46. PubMed ID: 17900801
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.
Tang P; Roldan G; Brasher PM; Fulton D; Roa W; Murtha A; Cairncross JG; Forsyth PA
J Neurooncol; 2006 Jul; 78(3):311-6. PubMed ID: 16710748
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of human glioma U-373MG cells to radiation and the protein kinase C inhibitor, calphostin C.
Acevedo-Duncan M; Pearlman J; Zachariah B
Cell Prolif; 2001 Feb; 34(1):31-41. PubMed ID: 11284917
[TBL] [Abstract][Full Text] [Related]
9. UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines.
Monks A; Harris ED; Vaigro-Wolff A; Hose CD; Connelly JW; Sausville EA
Invest New Drugs; 2000 May; 18(2):95-107. PubMed ID: 10857990
[TBL] [Abstract][Full Text] [Related]
10. Growth factors in gliomas: antisense and dominant negative mutant strategies.
Campbell JW; Pollack IF
J Neurooncol; 1997 Dec; 35(3):275-85. PubMed ID: 9440025
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen.
Baltuch GH; Couldwell WT; Villemure JG; Yong VW
Neurosurgery; 1993 Sep; 33(3):495-501; discussion 501. PubMed ID: 8413883
[TBL] [Abstract][Full Text] [Related]
12. Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways.
Pollack IF; Randall MS; Kristofik MP; Kelly RH; Selker RG; Vertosick FT
J Neurosurg; 1990 Jul; 73(1):98-105. PubMed ID: 2161913
[TBL] [Abstract][Full Text] [Related]
13. The role of protein kinase C (PKC) in the evolution and proliferation of malignant gliomas, and the application of PKC inhibition as a novel approach to anti-glioma therapy.
Bredel M; Pollack IF
Acta Neurochir (Wien); 1997; 139(11):1000-13. PubMed ID: 9442212
[TBL] [Abstract][Full Text] [Related]
14. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
Nagpal S
Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
[TBL] [Abstract][Full Text] [Related]
15. Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor.
Pollack IF; Kawecki S; Lazo JS
J Neurosurg; 1996 Jun; 84(6):1024-32. PubMed ID: 8847567
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion.
Bredel M; Pollack IF; Freund JM; Rusnak J; Lazo JS
J Neurooncol; 1999 Jan; 41(1):9-20. PubMed ID: 10222418
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
